Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News IQ Healthy Hearts ETF HART

The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ Candriam Healthy Hearts Index The Fund employs a passive management ¿ or indexing ¿ investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (ARCA:HART)

IndexIQ Launches New ESG Core Plus Bond ETF "ESGB" in Partnership with MacKay Shields

Business Wire June 29, 2021

New York Life Investments and American Heart Association Introduce Thematic ESG ETF Focused on Health and Wellbeing

PR Newswire February 1, 2021

Harvard Apparatus Regenerative Technology Changes Name to Biostage, Inc. (NASDAQ: BSTG)

PR Newswire March 31, 2016

Bioengineered Organ Implant Developer HART Reviews Progress and Q4 2015 Results

PR Newswire March 17, 2016

Bioengineered Organ Implant Developer HART To Host Q4 2015 Conference Call Thursday, March 17th at 5:00pm ET

PR Newswire March 8, 2016

HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HART's 2016 IND Submission For its Bioengineered Organ Implant Solutions

PR Newswire March 2, 2016

HART, Developing Bio-Engineered Organs for Life Threatening Conditions, CEO Clip Video

Newsfile February 26, 2016

Bioengineered Organ Implant Developer HART to Webcast BIO CEO Conference Presentation Tues., Feb. 9th at 8:00 am EST

PR Newswire February 3, 2016

Bioengineered Organ Implant Developer HART to Webcast Source Capital Disruptive Growth & Healthcare Conference Presentation Wed., Feb. 10th at 3:30 pm EST

PR Newswire February 1, 2016
View More News ››

Opinion & Analysis (ARCA:HART)

No current opinion is available.
View More Opinion ››

Bullboard Posts (ARCA:HART)

Huge news today, break out beyond 52 week high

It will take off from here, great deal confirmation.
BrokerAzB - November 12, 2015

Harvard Apparatus Regenerative Technology No Longer Supporti

Harvard Apparatus Regenerative Technology No Longer Supporting Studies in Russia; Will Continue Focus on Preclinical Processes in the U...
CommonCentsforDollars - November 28, 2014

The Company That Can Grow You A New Organ: A Promising Long-

The Company That Can Grow You A New Organ: A Promising Long-Term Investment http://seekingalpha.com/article/2617735-the-company-that...
CommonCentsforDollars - October 30, 2014

Harvard Apparatus Regenerative Technology Inc obtains Orphan

Harvard Apparatus Regenerative Technology Inc obtains Orphan Drug Designation from U.S. Food and Drug Administration for HART-Trachea...
CommonCentsforDollars - October 14, 2014

Regenerative medicine firm hires its first CMO

http://seekingalpha.com/news/1676743-regenerative-medicine-firm-hires-its-first-cmo
CommonCentsforDollars - April 16, 2014

Harvard Apparatus Regenerative Technology Collaborator Succe

Harvard Apparatus Regenerative Technology Collaborator Successfully Transplants Regenerated Esophagus into Rat http://www.marketwatch...
CommonCentsforDollars - April 15, 2014
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »